Explaining attitudes towards ambiguity: an experimental test of the comparative ignorance hypothesis

Title: Explaining attitudes towards ambiguity: an experimental test of the comparative ignorance hypothesis
Authors: Dolan, Paul and Jones, Martin
PublisherScottish journal of political economy, 51 (3). pp. 281-301
ISSN: 0036-9292
View Publication

Abstract: Many theories have been put forward to explain attitudes towards ambiguity. This paper reports on an experiment designed to test for the existence of Comparative Ignorance when it is tested over events with a range of different likelihoods. A total of 93 subjects valued a series of gambles, one of which was played out for real. The results do not lend support to the theory, although the relationship between risk and ambiguity does appear to correspond with other theories and previous empirical work.

Prescribing by general practitioners after an osteoporotic fracture

Title: Prescribing by general practitioners after an osteoporotic fracture
Authors: Torgerson, D. J and Dolan, Paul
PublisherAnnals of the rheumatic diseases, 57 (6). pp. 378-379.
ISSN: 0003-4967
View Publication

Abstract: OBJECTIVES Osteoporosis is a major cause of morbidity and cost. Patients sustaining one osteoporotic fracture are at increased risk of having another fracture. The objective of this study was to examine the use of “bone drugs” for the prevention of further osteoporotic fractures among patients who have had a “typical” osteoporotic fracture. METHODS This study took a random sample of 300 women aged 50 and over who had sustained either a vertebral, hip or Colles fracture in 1995 from the General Practice Research Database (GPRD) and compared their use of bone drugs with 300 age and practice matched controls. RESULTS Compared with age and practice matched control patients only vertebral fracture patients showed a statistically significant increase in the use of bone drugs in the year after fracture (39% and 2% for cases and controls respectively; 95% CI of difference 27% to 47%). Etidronate was the most commonly used compound. CONCLUSION The majority of patients sustaining an osteoporotic fracture are not prescribed any pharmaceutical agents for the secondary prevention of fracture one year after a primary fracture.